TIVA vs TXA in Sinus Surgery to Evaluate Operative Blood Loss and Surgical Field Quality
Sponsored by Our Lady of the Lake Hospital
About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Started 2 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- adults (age ≥18 years)
- will undergo endoscopic sinus surgery at Our Lady of the Lake Regional Medical Center
- includes patients who are undergoing endoscopic sinus surgery for myriad of indications, such as chronic rhinosinusitis, sinonasal tumors, and encephalocele repairs.
- includes patients who undergo both complete functional endoscopic sinus surgery, or FESS (i.e maxillary antrostomy, sphenoethmoidectomy, and frontal sinusotomy), as well as those who are undergoing limited functional endoscopic sinus surgeries (i.e. anything less than a complete FESS).
Exclusion Criteria
- <18 years of age
- history of bleeding or coagulation disorder
- currently receiving anticoagulation therapy
- underlying condition with increased risk of thrombosis (e.g. antiphospholipid syndrome),
- history of thromboembolic disorder
- history of chronic kidney disease
- known allergy to tranexamic acid